All news from Anaesthesiology

Novel Treatment for Leukemia Patients

According to new research by Queen Mary University of London, patients with an aggressive form of leukemia, currently ineligible for any type of targeted therapy, could benefit from some of the new drugs. The study findings published in the Nature journal Leukemia.

Correlations between Biomarkers and Alcohol Consumption in Gastric Cancer Patients

A new study published in The American Journal of Pathology reported that expression of DNA repair-related biomarkers (BRF1, BRCA1 / 2, and MPO) affected by alcohol can be linked to anticipated response to chemotherapy and survival of gastric cancer patients. It is the first time that a correlation between a key microRNA-processing modulator, transcription factor IIB-related factor 1 (BRF1), and prognosis of gastric cancer patients has been demonstrated.

Mild Traumatic Brain injury: Promising treatment with Transcranial Electrical Stimulation

Using a form of low-impulse electrical stimulation to the brain, documented by neuroimaging, researchers at the University of California San Diego School of Medicine, Veterans Affairs San Diego Healthcare System (VASDHS) and collaborators elsewhere, report significantly improved neural function in participants with mild traumatic brain injury (TBI). Their findings are published online in the current issue of the journal Brain Injury.

One HPV type Infection Strongly Increases Risk of Reinfection in Men

A new analysis of genital human papillomavirus (HPV) in men shows that infection with one HPV type strongly increases the risk of reinfection with the same type. In fact, men who are infected with the type responsible for most HPV-related cancers are 20 times more likely to be reinfected within one year. This increased risk suggests that infection confers no natural immunity against HPV, as is often the case with other viruses.

A New Weapon of Immune System to Fight Tuberculosis

A complete cure for tuberculosis has eluded scientists for more than a century but, now, a Montreal team of researchers may have discovered a new weapon to combat this global killer. The team is re-programming  immune cells to kill TB. These groundbreaking findings were published in the journal  Cell .